Should expect a good run very soon as phase II human trials of their Pentrix cancer vaccine are due to start in October. The current market cap is <$20 mill. 30 cents in one month looks very achievable (if not cheap) under the current environment.
ACU Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
